IQVIA Holdings Inc. (IQV) vs Natera, Inc. (NTRA)

IQVIA Holdings Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $58.4B against $44.6B — 1.3× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; IQVIA Holdings Inc. trades at 32.8×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 8.17%. IQVIA Holdings Inc. has the higher net margin (8.10% vs −7.11%) and the higher return on invested capital (6.80% vs −22.3%). Across the 20 metrics below, IQVIA Holdings Inc. leads on 14 and Natera, Inc. on 6.

Valuation

Metric IQV NTRA Diagnostics & Research median
P/E 32.83 n/m 35.56
P/S 2.61 20.75 4.37
P/B 7.04 30.83 3.06
Price to free cash flow 19.62 667.04 35.76
EV/EBITDA 17.10 n/m 24.35
EV/Sales 3.43 20.48 5.51
Earnings yield 3.05% (0.35%) (1.89%)
Free cash flow yield 5.10% 0.15% (0.15%)

Profitability

Metric IQV NTRA Diagnostics & Research median
Gross margin 32.97% 65.23% 50.89%
Operating margin 12.95% (10.70%) (8.57%)
Net margin 8.10% (7.11%) (6.37%)
Free cash flow margin 13.30% 3.11% 0.00%
Return on equity 22.75% (12.54%) (2.92%)
Return on assets 4.70% (8.71%) (6.71%)
Return on invested capital 6.80% (22.34%) 0.00%

Growth

Metric IQV NTRA Diagnostics & Research median
Revenue growth (TTM) 8.17% 37.82% 7.69%
EPS growth (last fiscal year) 4.67% 0.65% 25.92%
Revenue growth, 5-year CAGR 7.50% 42.61% 7.40%
Net income growth, 5-year CAGR 37.27% 0.00% 0.00%

Health

Metric IQV NTRA Diagnostics & Research median
Debt to equity 2.54 0.04 0.11
Current ratio 0.71 3.00 2.02
Net debt to EBITDA 4.06 3.74 0.70

Dividend

Metric IQV NTRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IQV NTRA Diagnostics & Research median
Market cap 44.61b 58.35b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack